6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetamide, N,N'-3,6,9,12,15,18,21-heptaoxatricosane-1,23-diylbis[4-(4-chlorophenyl)-2,3,9-trimethyl-, (6S,6'S)-;MT1 BET inhibitor
MT1 is a potent BET bromodomain inhibitor and an intramolecular bivalent BRD4 binder, exhibiting over 100-fold greater potency than the corresponding monovalent antagonist JQ1 in cellular assays; it significantly (P<0.05) delays leukemia progression in mice compared to JQ1.